Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor. | J Cardiovasc Pharmacol;28(6): 862-9, 1996 Dec. | MEDLINE

Main content 1 Search 2 Footer 3

+A A -A High contrast

VHL Regional Portal

Information and Knowledge for Health

Advanced Search EVID@Easy

Antiplatelet and antiproliferative effects of SCH 51866, a novel type 1 and type 5 phosphodiesterase inhibitor.

Vemulapalli, S; Watkins, R W; Chintala, M; Davis, H; Ahn, H S; Fawzi, A; Tulshian, D; Chiu, P; Chatterjee, M; Lin, C C; Sybertz, E J.

Affiliation

Vemulapalli S; Schering-Plough Research Institute, Kenilworth, NJ 07033, USA.

J Cardiovasc Pharmacol ; 28(6): 862-9, 1996 Dec.

Article in En | MEDLINE | ID: mdl-8961086

Subject(s)

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Blood Platelets / Platelet Aggregation Inhibitors / 3',5'-Cyclic-GMP Phosphodiesterases / Phosphoric Diester Hydrolases / Enzyme Inhibitors / Hypertension / Imidazoles / Nucleotides, Cyclic Limits: Animals / Humans Language: En Journal: J Cardiovasc Pharmacol Year: 1996 Document type: Article Affiliation country: Country of publication:

Search on Google

Collection: 01-internacional Database: MEDLINE Main subject: Phosphodiesterase Inhibitors / Blood Platelets / Platelet Aggregation Inhibitors / 3',5'-Cyclic-GMP Phosphodiesterases / Phosphoric Diester Hydrolases / Enzyme Inhibitors / Hypertension / Imidazoles / Nucleotides, Cyclic Limits: Animals / Humans Language: En Journal: J Cardiovasc Pharmacol Year: 1996 Document type: Article Affiliation country: Country of publication: